Viewing Study NCT03599518


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2025-12-26 @ 3:58 AM
Study NCT ID: NCT03599518
Status: TERMINATED
Last Update Posted: 2023-02-08
First Post: 2018-07-16
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: DS-1205c With Gefitinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
Sponsor: Daiichi Sankyo Co., Ltd.
Organization: